1. Home
  2. LNSR

as 12-18-2024 12:39pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Medical Electronics

Nasdaq

LENSAR Inc is a commercial-stage medical device company focused on designing, developing and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency and reproducibility by providing imaging, simplified procedure planning, efficient design and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. The consumable portion of the system consists of a disposable patient interface device, or PID, kit and a procedure license. Each procedure on each system requires the use of a PID kit.

Founded: 2004 Country:
United States
United States
Employees: N/A City: ORLANDO
Market Cap: 63.4M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 47.6K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.46 EPS Growth: N/A
52 Week Low/High: $2.33 - $8.17 Next Earning Date: 11-07-2024
Revenue: $48,868,000 Revenue Growth: 21.29%
Revenue Growth (this year): 25.07% Revenue Growth (next year): 24.95%

LNSR Daily Stock ML Predictions

Share on Social Networks: